Veronique Lecault

All filings by Veronique Lecault on record concern AbCellera Biologics Inc., in the capacity of chief executive. Between 9 June 2021 and 21 June 2024, the trades on record add up to 10 filings.

Both buying and selling appear: 3 purchases worth €3.1M, against 1 sale worth €20.9M. On balance, insiders were net sellers of €17.8M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 6 option exercises.

A typical purchase (the median) is worth €1.2M. Of 3 purchases, 1 formed part of a group of insiders buying within 30 days of each other. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.

The record was last updated on 24 June 2024 with an option exercise (€15k) in AbCellera Biologics Inc. The latest purchase dates back some time: it was published 1,130 days ago, on 14 September 2023. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.